{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:14:27Z","timestamp":1781774067055,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.vaccine.2005.08.048","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T07:29:37Z","timestamp":1124954977000},"page":"4554-4561","source":"Crossref","is-referenced-by-count":92,"title":["Synergistic DNA\u2013MVA prime-boost vaccination regimes for malaria and tuberculosis"],"prefix":"10.1016","volume":"24","author":[{"given":"Sarah C.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasee S.","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansar A.","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"McConkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni M.","family":"Vuola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila M.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Berthoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.08.048_bib1","unstructured":"World Health Organisation. Malaria Fact Sheet No. 94; 1996."},{"issue":"9289","key":"10.1016\/j.vaccine.2005.08.048_bib2","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(01)06344-9","article-title":"Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania","volume":"358","author":"Mutabingwa","year":"2001","journal-title":"Lancet"},{"issue":"5591","key":"10.1016\/j.vaccine.2005.08.048_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.1078052","article-title":"An overview of insecticide resistance","volume":"298","author":"Hemingway","year":"2002","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2005.08.048_bib4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm785","article-title":"Migration through host cells activates plasmodium sporozoites for infection","volume":"8","author":"Mota","year":"2002","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.vaccine.2005.08.048_bib5","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1073\/pnas.90.11.5214","article-title":"Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria","volume":"90","author":"Li","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.048_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T-cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.048_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.048_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0264-410X(98)00238-2","article-title":"Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime","volume":"17","author":"Hanke","year":"1999","journal-title":"Vaccine"},{"issue":"6812","key":"10.1016\/j.vaccine.2005.08.048_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2005.08.048_bib10","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.4049\/jimmunol.168.9.4391","article-title":"Competition between CTL narrows the immune response induced by prime-boost vaccination protocols","volume":"168","author":"Palmowski","year":"2002","journal-title":"J Immunol"},{"issue":"5514","key":"10.1016\/j.vaccine.2005.08.048_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.1058915","article-title":"Control of a mucosal challenge and prevention of AIDS by a multi-protein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2005.08.048_bib12","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.4049\/jimmunol.172.5.3094","article-title":"Enhanced CD8+ T-cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunisation regimens using a novel attenuated fowlpox virus","volume":"172","author":"Anderson","year":"2004","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.08.048_bib13","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1086\/515288","article-title":"Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS vaccine evaluation group","volume":"177","author":"Clements-Mann","year":"1998","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2005.08.048_bib14","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nbt1197-1280","article-title":"A protein particle vaccine containing multiple malaria epitopes","volume":"15","author":"Gilbert","year":"1997","journal-title":"Nat Biotechnol"},{"issue":"1305","key":"10.1016\/j.vaccine.2005.08.048_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1098\/rspb.1990.0126","article-title":"Polymorphism of the TRAP gene of Plasmodium falciparum","volume":"242","author":"Robson","year":"1990","journal-title":"Proc R Soc London Ser B: Biol Sci"},{"issue":"8956","key":"10.1016\/j.vaccine.2005.08.048_bib16","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0140-6736(95)90754-8","article-title":"Identification of conserved antigenic components for a cytotoxic T-lymphocyte-inducing vaccine against malaria","volume":"345","author":"Aidoo","year":"1995","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.vaccine.2005.08.048_bib17","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Non-replicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.08.048_bib18","first-page":"195","article-title":"Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus","volume":"84","author":"Sutter","year":"1995","journal-title":"Dev Biol Stand"},{"issue":"Part 2","key":"10.1016\/j.vaccine.2005.08.048_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1099\/vir.0.19568-0","article-title":"Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of fowlpox virus, with those of virulent American and European viruses","volume":"85","author":"Laidlaw","year":"2004","journal-title":"J Gen Virol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2005.08.048_bib20","first-page":"2004","article-title":"Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers","volume":"21","author":"Moorthy","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.048_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat Med"},{"issue":"19","key":"10.1016\/j.vaccine.2005.08.048_bib22","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1073\/pnas.181123498","article-title":"Induction of CD4(+) T-cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine","volume":"98","author":"Wang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.048_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4049\/jimmunol.174.1.449","article-title":"Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers","volume":"174","author":"Vuola","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.048_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.174.2.1037","article-title":"Functional heterogeneity of memory CD4 T-cell responses in different conditions of antigen exposure and persistence","volume":"174","author":"Harari","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.048_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity in humans of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2005.08.048_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/427243","article-title":"Calculation of liver-to-blood inocula, parasite growth rates, and pre-erythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites","volume":"191","author":"Bejon","year":"2005","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2005.08.048_bib27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/378515","article-title":"Safety and immunogenicity of DNA\/modified vaccinia virus Ankara malaria vaccination in African adults","volume":"188","author":"Moorthy","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.048_bib28","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.pmed.0010033","article-title":"A randomised, double-blind, controlled vaccine efficacy trial of DNA\/MVA ME-TRAP against malaria infection in Gambian adults","volume":"1","author":"Moorthy","year":"2004","journal-title":"Plos Med"},{"issue":"12","key":"10.1016\/j.vaccine.2005.08.048_bib29","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1086\/421118","article-title":"Phase 1 evaluation of three highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men","volume":"189","author":"Moorthy","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.048_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4049\/jimmunol.171.1.27","article-title":"Cutting edge: rapid in vivo killing by memory CD8 T-cells","volume":"171","author":"Barber","year":"2003","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2005.08.048_bib31","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.048_bib32","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.08.048_bib33","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/IAI.72.12.6945-6950.2004","article-title":"A heterologous DNA priming Mycobacterium bovis BCG boosting immunisation strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice","volume":"72","author":"Ferraz","year":"2004","journal-title":"Infect Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2005.08.048_bib34","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/IAI.71.9.4901-4907.2003","article-title":"A DNA prime Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis","volume":"71","author":"Skinner","year":"2003","journal-title":"Infect Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.048_bib35","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette\u2013Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.08.048_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","article-title":"Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette\u2013Guerin","volume":"112","author":"Vordermeier","year":"2004","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.vaccine.2005.08.048_bib37","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired anti-mycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.048_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/IAI.71.1.483-493.2003","article-title":"Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from mycobacterium tuberculosis","volume":"71","author":"D'Souza","year":"2003","journal-title":"Infect Immunol"},{"issue":"9315","key":"10.1016\/j.vaccine.2005.08.048_bib39","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2005.08.048_bib40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2005.08.048_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2005.73.191","article-title":"Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials","volume":"73","author":"Andrews","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"13","key":"10.1016\/j.vaccine.2005.08.048_bib42","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1073\/pnas.0406381102","article-title":"Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara","volume":"102","author":"Webster","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2005.08.048_bib43","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05008182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05008182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T06:29:44Z","timestamp":1552890584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05008182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":43,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0264410X05008182"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.08.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}